Autopsy report · NCT05481905
ENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal Seizures
Cause of deathFunding or business
“Business decision”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2
- Sponsor
- Engrail Therapeutics INC
- Sponsor type
- Industry
- Conditions
- Focal Epilepsy
- Interventions
- ENX-101
- Participants
- 0
- Sites
- 38
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.